Neurological patients need evidence-based urological care

Neurourology and Urodynamics

Volumn 29, Issue 4, 2010, Pages 662-669

  Wyndaele, J J ^a   Bruschini, H ^b   Madersbacher, H ^c   Moore, K ^d   Pontari, M ^e   Wein, A ^f  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^d UNIVERSITY OF ALBERTA   (Canada)

^e TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Diagnosis; Epidemiology; Evidence based; Neurologic bladder; Treatment

Indexed keywords

BOTULINUM TOXIN A; DARIFENACIN; FESOTERODINE; OXYBUTYNIN; PLACEBO; PROPIVERINE; SOLIFENACIN; TOLTERODINE; TROSPIUM CHLORIDE;

BLADDER CATHETERIZATION; BLADDER PRESSURE; CONFERENCE PAPER; CYSTOSTOMY; DENERVATION; DETRUSOR MUSCLE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENDOSCOPIC SURGERY; EVIDENCE BASED MEDICINE; HUMAN; INTERMITTENT CATHETERIZATION; LOWER URINARY TRACT SYMPTOM; NEUROGENIC BLADDER; NEUROLOGIC LOWER URINARY TRACT DYSFUNCTION; NON INVASIVE PROCEDURE; OVERACTIVE BLADDER; PREVALENCE; PYELOGRAPHY; SPHINCTEROTOMY; URETHRA; URETHRA DISEASE; URINARY DIVERSION; URINARY TRACT INFECTION; URODYNAMICS;

EVIDENCE-BASED MEDICINE; HUMANS; NERVOUS SYSTEM DISEASES; NEUROLOGY; PREVALENCE; URINARY BLADDER; URINARY BLADDER DISEASES; URINARY BLADDER, NEUROGENIC; UROLOGY;

EID: 77953572559     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20866     Document Type: Conference Paper

References (72)

1. Abrams P, Khoury S, Grant A. Evidence-based medicine overview of themain steps for developing and grading guideline recommendations. In: Abrams P, Cardozo L, Khoury S, Wein A, editors. Incontinence. Editions 21. Paris. 2005. pp. 10-11.
2. New PW. Non-traumatic spinal cord injury: What is the ideal setting for rehabilitation? Aust Health Rev 2006;30:353-361
3. Curling TB. Essay on affections of the bladder in paraplegia. London Medical Gazette 1833;13:78-80.
4. Hugonet P, Dejerine M. Les grands infirmes par troubles des centres nerveux. Extrait de conférence interalliée pour l 0étude de la rééducation professionnelle et des questions qui intéressent les invalides de guerre. Grand palais Paris 1917, tome 3. Paris: Imprimerie Choix 1919.
5. Munro AF, Hahn J. Tidal drainage of the urinary bladder. N Engl J Med 1935;212:229-237
6. Guttmann L, Frankel H. The value of intermittent catheterization in the early management of traumatic paraplegia and tetraplegia. Paraplegia 1966;4:63-83.
7. Lapides J, Diokno A, Silber S, et al. Clean intermittent self-catheterization in the treatment of urinary tract disease. J Urol 1972;107:458-461
8. Feifer A, Corcos J. Contemporary role of suprapubic cystostomy in treatment of neuropathic bladder dysfunction in spinal cord injured patients. Neurourol Urodyn 2008;27:475-479
9. Wyndaele JJ, Kovindha A, Medersbacher H., et al. Neurologic urinary and faecal incontinence. In: Abrams P, Cardozo L, Khoury S, Wein A, editors. Incontinence. Paris: Health Publication; 2009. pp 793-960.
10. Bödeker J, Nagel R. Intravesical and intraurethral pressure studies: Significance for the prognosis and the treatment of children with myelomeningocele. Urologe A 1977;16:258-266
11. McGuire EJ, Woodside JR, Borden TA, et al. Prognostic value of urodynamic testing in myelodysplastic patients. J Urol 1981;126:205-209
12. Flood HD, Ritchey ML, Bloom DA, et al. Outcome of reflux in children with myelodysplasia managed by bladder pressure monitoring. J Urol 1994; 152:1574-1577
13. Bruschini H, Almeida FG, Srougi M. Upper and lower urinary tract evaluation of 104 patients with myelomeningocele without adequate urological management. World J Urol 2006;24:224-228
14. Blaivas JG, Sinha HP, Zayed AA, et al. Detrusor-external sphincter dyssynergia: A detailed electromyographic study. J Urol 1981;125:545-548
15. Linsenmeyer TA. Update on bladder evaluation recommendations and bladder management guideline in patients with spinal cord injury. Curr Bladder Dysfunct Rep 2007;2:134-140
16. Tsai SJ, Tinig H, Ho CC, et al. Use of sonography and radioisotope renography to diagnose hydronephrosis in patients with spinalcord injury. Arch Phys Med Rehab 2001;82:103-106
17. Bih LI, Changlai SP, Ho CC, et al. Application of isotope renography with technetium-99 mercapto-acetyltriglycine on patients with spinal cord injuries. Arch Phys Med Rehabil 1994;75:982-986
18. Kessler TM, Lackner J, Kiss G, et al. Early proactive management improves upper urinary tract function and reduces the need for surgery in patients with myelomeningocele. Neurourol Urodyn 2006;25:758-762
19. Papadaki PJ, Vlychou MK, Zavras GM, et al. Investigation of vesicoureteral reflux with colour Doppler sonography in adult patients with spinal cord injury. Eur Radiol 2002;12:366-370
20. DrakeMJ, Cortina-Borja M, Savie G, et al. Prospective evaluation of urological effects of aging in chronic spinal cord injury by method of bladder management. Neurourol Urodyn 2005;24:111-116
21. Pontari MA, McNaughton-Collins M, O'leary MP, et al. The CPCRN Study Group. A case-control study of risk factors in men with chronic pelvic pain syndrome. BJU Int 2005;96:559-565
22. Simon LJ, Landis JR, Erickson DR, et al. The Interstitial Cystitis Data Base Study: Concepts and preliminary baseline descriptive statistics. Urology 1997;49:64-75.
23. Griffiths D, Derbyshire S, Stenger A, et al. Brain control of normal and overactive bladder. J Urol 2005;174:1862-1867
24. Mezzapesa DM, Rocca MA, Rodegher M, et al. Functional cortical changes of the sensorimotor network are associated with clinical recovery in multiple sclerosis. Human Brain Mapping 2008;29:562-573
25. Campbell JB, Moore KN, Voaklander DC, et al. Complications associated with clean intermittent catheterization in children with spina bifida. J Urol 2004;171:2420-2422
26. Wyndaele JJ. Complications of intermittent catheterization: Their prevention and treatment. Spinal Cord 2002;40:536-541
27. Moore KN. Two methods for cleaning catheters used for intermittent catheterization: Sunlight1 liquid detergent and Cetrimide 1:30 (Savlon1). Can J Rehab 1990;4:87-92.
28. Getliffe K, Fader M, Allen C, et al. Current evidence on intermittent catheterization: Sterile single-use catheters or clean reused catheters and the incidence of UTI. J Wound Ostomy Contin Nursing 2007;34: 289-296
29. Vaidyanathan S, Soni BM, Dundas S, et al. Urethral cytology in spinal cord injury patients performing intermittent catheterisation. Paraplegia 1994;32:493-500.
30. Igawa Y, Wyndaele JJ, Nishizawa O. Catheterization: Possible complications and their prevention and treatment. Int J Urol 2008;15:481-485
31. Cottenden A, Bliss DZ, Buckely B, et al. Management using continence products. In: Abrams P, Cardozo L, Khoury S, Wein A, editors. Incontinence: 4th International Consultation on Incontinence. Paris: Health Publication Ltd.; 2009. pp 1521-1624
32. Moore KN, Fader M, Getliffe K. Intermittent catheterization techniques for adults and children. (Cochrane Review). In: The Cochrane Library August 2007.Oxford: Update Software (2007).
33. Moore KN, Burt J, Voaklander DC. Intermittent Catheterization in the rehabilitation setting: A comparison of clean and sterile technique. Clin Rehabil 2006;20:461-468
34. Moore KN, Kelm M, Sinclair O, et al. Bacteriuria in intermittent catheterization users: The effect of sterile versus clean reused catheters. Rehabil Nurs 1993;18:306-309
35. Schlager TA, Clark M, Anderson S. Effect of a single-use sterile catheter for each void on the frequency of bacteriuria in children with neurogenic bladder on intermittent catherization for bladder emptying. Pediatrics 2002;108:e71.
36. Duffy LM, Cleary J, Ahern S, et al. Clean intermittent catheterization: Costeffective bladder management for male residents of VA nursing homes. American Geriatr Soc 1995;43:865-870
37. King RB, Carlson CE, Mervine J, et al. Clean and sterile intermittent catherterization methods in hospitalized patients with spinal cord injury. Arch Phys Med Rehab 1992;73:798-802.
38. Day RA, Moore KN, Albers MK. A pilot study comparing two methods of intermittent catheterization: Limitations and challenges. Urol Nursing 2003;23:143-158
39. Prieto-Fingerhut T, Banovac K, Lynne CM. A study comparing sterile and nonsterile urethral catheterization in patients with spinal cord injury. Rehabil Nursing 1997;22:299-301.
40. Quigley PA, Riggin OZ. A comparison of open and closed catheterization techniques in rehabilitation patients. Rehabil Nursing 1993;18:26-33.
41. Giannantoni A, Di Stasi SM, Scivoletto G, et al. Intermittent catheterization with a prelubricated catheter in spinal cord injured patients: A prospective randomized crossover study. J Urol 2001;166:130-133
42. Pachler J, Frimodt-Möller C. A comparison of prelubricated hydrophilic and non-hypdrophillic polyvinyl chloride catheters for urethral catheterization. BJU Int 1999;83:767-769
43. Sutherland RS, Kogan BA, Baskin LS, et al. Clean intermitent catheterization in boys using the lofric catheter. J Urol 1996;156:2041-2043
44. Vapnek JM, Maynard FM, Kim J. A prospective randomized trial of the lofric hydrophilic coated catheter versus conventional plastic catheter for clean intermittent catheterization. J Urol 2003;169:994-998
45. De Ridder DJMK, Everaert K, Garcia Fernandez L, et al. Intermittent catheterisation with hydrophilic-coated catheters (Speedicath) reduces the risk of clinical urinary tract infection in spinal cord injured patients: A prospective randomised parallel comparative trial. Eur Urol 2005;48: 991-995
46. NIDRR. National Institute on Disability and Rehabilitation Research Consensus Statement: The prevention and management of urinary tract infections among people with spinal cord injuries. JAPS 1992;15:194-207.
47. Stöhrer M, Frohneberg D, Loechner-Ernst D, et al. Oxybutynin in der Therapie der Detrusorhyperreflexie bei Patienten mit Rü ckenmarkverletzungen. Eine multizentrische randomisierte Doppelblindstudie. Z Urologie Poster 3/1990. 184-185.
48. Stöhrer M, Bauer P, Giannetti BM, et al. Effect of trospium chloride on urodynamic parameters in patients with detrusor hyperreflexia due to spinal cord injuries. A multicentre placebo-controlled double-blind trial. Urol Int 1991;47:138-143
49. Menarini M, Del Popolo G, Benedetto D, et al. Trospium chloride in patients with neurogenic detrusor overactivity: Is dose titration of benefit to the patients ? Int J Clin Pharmacol Ther 2006;44:623-632
50. Bennett N, O'LearyM, Patel AS, et al. Can higher doses of oxybutynin improve efficacy in neurogenic bladder ? J Urol 2004;171:749-751
51. Stöhrer M, Madersbacher H, Richter R, et al. Efficacy and safety of propiverine in SCI-patients suffering from detrusor hyperreflexia-A double-blind, placebo-controlled clinical trial. Spinal Cord 1999;37:196-200.
52. Van Kerrebroeck P, Amarenco G, Thüroff J, et al. Dose-ranging study of tolterodine in patients with detrusor hyperreflexia. Neurourol Urodyn 1998:499-512.
53. Geirsson G, Schoffield D, Haughie S, et al. Assessment of time to onset: The effect of single oral dose of tolterodine on neurogenic detrusor overactivity in spinal cord injury patients. Annual meeting of the International Continence Society, 2006.
54. Bycroft J, Leaker B, Wood S, et al. The effect of darifenacin on neurogenic dtrusor overactivity in patients with spinal cord injury. Abstract. Annual meeting of the International Continence Society, Florence, Italy, 2003.
55. Amend B, Hennenlotter J, Schaefer T, et al. Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects. Eur Urol 2008;53:1021-1028
56. Gajewski JB, Awad SA. Oxybutynin versus propantheline in patients with multiple sclerosis and detrusor hyperreflexia. J Urol 1986;135:966-968
57. Ethans KD, Nance PW, Bard RJ, et al. Efficacy and safety of tolterodine in people with neurogenic detrusor overactivity. J Spinal Cord Med 2004;27: 214-218
58. Madersbacher H, Stöhrer M, Richter R, et al. Trospium chloride versus oxybutynin: A randomized, double-blind, multicentre trial in the treatment of detrusor hyperreflexia. Bri Urol 1995;75:452-456
59. Stöhrer M, Mürtz G, Kramer G, et al. Propiverine Study Group. Propiverine compared to oxybutynin in neurogenic detrusor overactivity-Results of a randomized, double blind, multicenter clinical study. Eur Urol 2007;51: 235-242
60. Stöhrer M, Mürtz G, Kramer G, et al. Efficacy and tolerability of propiverine hydrochloride extended release compared to immediate release in patients with neurogenic detrusor overactivity. Abstract. Annual meeting of the International Continence Society, San Francisco, USA, 2009.
61. Giannantoni A, Mearini E, Del Zingaro M, et al. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: Clinical and urodynamic results. Eur Urol 2009;55:705-711
62. Da Silva CM, Cruz F. Has botulinum toxin therapy become of age:What dowe know, what do we need to know, and should we use it? Curr Opin Urol 2009;19:347-352
63. Apostolidis A, Dasgupta P, Denys P, et al. Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: A European Consensus Report. Eur Urol 2009;55: 100-120
64. Wyndaele JJ, Van Dromme SA. Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity. Spinal Cord 2002;40:599-600.
65. De Laet K, Wyndaele JJ. Adverse events after botulinum A toxin injection for neurogenic voiding disorders. Spinal Cord 2005;43:397-399
66. Sammour ZM, Gomes CM, Barbosa ER, et al. Voiding dysfunction in patients with Parkinson's disease: Impact of neurological impairment and clinical parameters. Neurourol Urodyn 2009;28:510-515
67. Pannek J, Kullik B. Does optimizing bladder management equal optimizing quality of life? Correlation between health-related quality of life and urodynamic parameters in patients with spinal cord lesions. Urology 2009;74:263-266
68. Lombardi G, Del Popolo G. Clinical outcome of sacral neuromodulation in incomplete spinal cord injured patients suffering from neurogenic lower urinary tract symptoms. Spinal Cord 2009;47:486-491
69. Pan D, Troy A, Rogerson J, et al. Long-term outcomes of external sphincterotomy in a spinal injured population. J Urol 2009;181:705-709
70. Chen JL, Kuo HC. Long-term outcomes of augmentation enterocystoplasty with an ileal segment in patients with spinal cord injury. J Formos Med Assoc 2009;108:475-480
71. Snodgrass W, Keefover-Hicks A, Prieto J, et al. Comparing outcomes of slings with versus without enterocystoplasty for neurogenic urinary incontinence. J Urol 2009;181:2709-2714
72. Abrams P, Agarwal M, Drake M, et al. Proposed guideline for the urological management of patients with spinal cord injury. BJU Int 2008;101: 989-994